# HCA Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2023

- Company: [HCA Healthcare, Inc.](/companies/hca.md) (CIK 860730)
- Form: 10-Q
- Filed: 2023-04-27
- Accepted by EDGAR: Apr 27, 2023, 16:31 ET
- Period: 2023-03-31
- Accession: 0000950170-23-015314
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/860730/000095017023015314/hca-20230331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/860730/000095017023015314/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2023-01-01 to 2023-03-31 | $15.59bn | us-gaap:Revenues |
| Interest expense | 3 months, 2023-01-01 to 2023-03-31 | $479.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-01-01 to 2023-03-31 | $379.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-01-01 to 2023-03-31 | $1.36bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-01-01 to 2023-03-31 | $4.85 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-01-01 to 2023-03-31 | $4.92 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-01-01 to 2023-03-31 | 280,961,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2023-01-01 to 2023-03-31 | $1.80bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2023-01-01 to 2023-03-31 | $1.20bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2023-01-01 to 2023-03-31 | $175.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2023-01-01 to 2023-03-31 | $846.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2023-03-31 | $842.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-03-31 | $13.54bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-03-31 | $52.71bn | us-gaap:Assets |
| Current liabilities | at 2023-03-31 | $11.03bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2023-03-31 | $36.48bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2023-03-31 | $2.38bn | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-03-31 | −$2.50bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/860730/000095017023015314/hca-20230331.htm

Filed Apr 27, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-015314. Last ingested by Listed: Nov 11, 2026, 03:15 ET. No prices; not investment advice.
